FORM OF AMENDMENT, WAIVER AND PURCHASE AGREEMENTWaiver and Purchase Agreement • May 31st, 2022 • Rapid Therapeutic Science Laboratories, Inc. • Pharmaceutical preparations • New York
This Amendment, Waiver and Purchase Agreement (this “Agreement”) is made and entered into as of May 31, 2022 (the “Effective Date”) by and between Rapid Therapeutic Science Laboratories, Inc. (the “Company”) and ________________ (the “Purchaser” and together with the Company, the “Parties”) for the purpose of, among other things, (i) amending that certain Original Issue Discount Convertible Debenture due May 1, 2022 (the “Original Debenture”), (ii) amending that certain Common Stock Purchase Warrant to purchase 194,118 shares of Common Stock (after giving effect to the 1-for-25 reverse split on March 31, 2022) issued to the Purchaser (the “Original Warrant”), (iii) waiving any and all prior and currently existing events of default under the Original Debenture as of the date hereof, and (iv) agreeing to the purchase and sale of a new Original Issue Discount Convertible Debenture (in the form attached as Exhibit A hereto, the “New Debenture”) and common stock purchase warrant to purchase
FORM OF SECOND AMENDMENT, WAIVER AND PURCHASE AGREEMENTWaiver and Purchase Agreement • August 23rd, 2023 • Rapid Therapeutic Science Laboratories, Inc. • Pharmaceutical preparations • New York
This Second Amendment, Waiver and Purchase Agreement (this “Agreement”) is made and entered into as of August 22, 2023 (the “Effective Date”) by and between Rapid Therapeutic Science Laboratories, Inc. (the “Company”) and __________ (the “Purchaser” and together with the Company, individually a “Party” and collectively the “Parties”) for the purpose of, among other things, (i) amending that certain Original Issue Discount Convertible Debenture issued on August 4, 2021 due September 1, 2022, as amended, (the “August Debenture”) and that certain Original Issue Discount Convertible Debenture issued on May 31, 2022 due September 1, 2022 (the “May Debenture”, collectively, with the August Debenture, the “Debentures”), (ii) amending that certain Common Stock Purchase Warrant to purchase shares of Common Stock issued to the Purchaser on August 4, 2021, as amended, (the “August Warrant”) and that certain Common Stock Purchase Warrant to purchase shares of Common Stock issued to the Purchaser o
